CIMZIA

Trials studying CIMZIA

• phase3A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritiscompletedn=359
• phase3A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasiscompletedn=49
• —CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)no longer available
• —Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)available
• phase3Pediatric Arthritis Study of Certolizumab Pegolcompletedn=193
• phase1A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)completedn=22
• phase4IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIAcompletedn=32
• phase1A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritiscompletedn=33